Pluvicto

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Fri, 04/5/24 - 11:37 am
Novartis
Pluvicto
prostate cancer
clinical trials
radioligands
Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data
BioSpace
Tue, 10/24/23 - 09:54 am
ESMO
Novartis
prostate cancer
Pluvicto
radiopharmaceuticals
Novartis plant cleared to produce in-demand cancer drug
BioPharma Dive
Mon, 04/24/23 - 10:59 pm
Novartis
drug manufacturing
Pluvicto
New Jersey
cancer
radiopharmaceuticals
Novartis takes step toward expanding supply of in-demand cancer drug
Biopharma Dive
Sun, 03/5/23 - 03:09 pm
Novartis
Pluvicto
prostate cancer
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise
BioSpace
Mon, 12/5/22 - 10:58 am
Novartis
prostate cancer
Pluvicto
clinical trials
patents
patent cliff
Lantheus has three shots on goal to challenge Novartis
EP Vantage
Wed, 11/16/22 - 10:19 am
Lantheus Medical
Novartis
Point Biopharma
Pluvicto
Luthathera
Novartis' surprise radiotherapy production halt nearing an end as FDA docs shed light on plant woes
Fierce Pharma
Thu, 06/2/22 - 10:20 am
Novartis
radiotherapy
FDA
Lutathera
Pluvicto
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
Motley Fool
Mon, 05/2/22 - 11:57 am
Novartis
M&A
AveXis
Zolgensma
Endocyte
Pluvicto
The Medicines Company
Levqio